Nautilus Biotechnology, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Nautilus Biotechnology, Inc. (NAUT) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 3.74 million shares for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-09-18.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2020-09-18
- Nautilus Biotechnology, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 3.74M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month |
|---|---|
| 2020-06-30 | 3.74M shares 10-Q · filed 2020-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |